Moving Forward Using Lessons Learned to Prevent Central Line-Associated Bloodstream Infections (CLABSI) June 23, 2022 – Part 2 of the 5-part Joint HQIC ‘Preventing Healthcare Associated Infections’ Learning & Action Network Series.

illustration of red blood cells

Prepared by IPRO HQIC

Preventing CLABSI remains a national patient safety priority given its associated harms of increased hospital length of stay, costs, morbidity and a 12–25 percent mortality rate. Recent studies have shown that during the COVID-19 pandemic, many hospitals experienced a significant increase in their CLABSI rates. This dynamic webinar features proactive strategies and tools for preventing all-cause harm related to CLABSI and showcases a hospital’s success with engaging leaders, providers and front-line staff in a hospital-wide initiative to drive down device utilization, increase bundle compliance and improve outcomes.

Flyer

Slide Deck

Recording of presentation